Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Data support use of TLK-286 in combination chemotherapy

Dec. 2, 2002

Simultaneous inhibition of angiogenesis and tumor growth with human MAb targeting integrins

Dec. 2, 2002

Aclacinomycin analogues produced by Finnish scientists using combinatorial biosynthesis

Dec. 2, 2002

SAR on a novel series of pyrrolobenzodiazepine antitumor agents

Dec. 2, 2002

U.K. team designs potent inhibitors of CDK1/CDK2 as potential anticancer agents

Dec. 2, 2002

Sumitomo researchers identify new chemopreventive agents

Dec. 2, 2002

Preclinical antitumor activity of FK-228

Dec. 2, 2002

Phase I findings for AP-5280 support initiation of phase I/II trial

Nov. 29, 2002

Potential new kinase inhibitors for potentiating the effects or radio- and/or chemotherapy

Nov. 29, 2002

NDA for palonosetron accepted for filing by the FDA

Nov. 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...